Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1991

1.

Structural insights into the potential changes in receptor binding site found in the 1998-2018 influenza B/Yamagata hemagglutinin: A putative correlation between receptor binding site structural variability and seasonal infection.

Cueno ME, Iguchi K, Suemitsu K, Hirano M, Hanzawa K, Isoda T, Ueno M, Iguchi R, Otani A, Imai K.

J Mol Graph Model. 2020 Mar 8;97:107580. doi: 10.1016/j.jmgm.2020.107580. [Epub ahead of print]

PMID:
32193088
2.

Successful liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).

Kripps K, Nakayuenyongsuk W, Shayota BJ, Berquist W, Gomez-Ospina N, Esquivel CO, Concepcion W, Sampson JB, Cristin DJ, Jackson WE, Gilliland S, Pomfret EA, Kueht ML, Pettit RW, Sherif YA, Emrick LT, Elsea SH, Himes R, Hirano M, Van Hove JLK, Scaglia F, Enns GM, Larson AA.

Mol Genet Metab. 2020 Mar 6. pii: S1096-7192(20)30060-3. doi: 10.1016/j.ymgme.2020.03.001. [Epub ahead of print]

PMID:
32173240
4.

Effects of Cytoreductive Surgery Combined with Perioperative Chemotherapy on Long-Term Survivals of Colorectal Cancer Patients with Peritoneal Metastasis, with Special Reference to the Involved Peritoneal Sectors and Organs.

Yonemura Y, Prabhu A, Sako S, Ishibashi H, Hirano M, Mizumoto A, Takao N, Ichinose M, Motoi S, Liu Y, Nishihara K, Fushida S.

Gan To Kagaku Ryoho. 2019 Dec;46(13):1917-1921.

PMID:
32157012
5.

Characterization of tick-borne encephalitis virus isolated from a tick in central Hokkaido in 2017.

Takahashi Y, Kobayashi S, Ishizuka M, Hirano M, Muto M, Nishiyama S, Kariwa H, Yoshii K.

J Gen Virol. 2020 Mar 5. doi: 10.1099/jgv.0.001400. [Epub ahead of print]

PMID:
32134377
6.

The development of resilience in Japanese adults: A two-wave latent change model.

Ueno Y, Hirano M, Oshio A.

Health Psychol Open. 2020 Feb 7;7(1):2055102920904726. doi: 10.1177/2055102920904726. eCollection 2020 Jan-Jun.

7.

Choriogenin transcription in medaka embryos and larvae as an alternative model for screening estrogenic endocrine-disrupting chemicals.

Ishibashi H, Uchida M, Temma Y, Hirano M, Tominaga N, Arizono K.

Ecotoxicol Environ Saf. 2020 Apr 15;193:110324. doi: 10.1016/j.ecoenv.2020.110324. Epub 2020 Feb 20.

PMID:
32088548
8.

H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant.

Maeda S, Ohka F, Okuno Y, Aoki K, Motomura K, Takeuchi K, Kusakari H, Yanagisawa N, Sato S, Yamaguchi J, Tanahashi K, Hirano M, Kato A, Shimizu H, Kitano Y, Yamazaki S, Yamashita S, Takeshima H, Shinjo K, Kondo Y, Wakabayashi T, Natsume A.

Acta Neuropathol Commun. 2020 Feb 5;8(1):8. doi: 10.1186/s40478-020-0882-4.

9.

Interocular symmetry of the foveal avascular zone area in healthy eyes: a swept-source optical coherence tomography angiography study.

Liu M, Fujiwara A, Morizane Y, Kawasaki R, Kimura S, Morizane-Hosokawa M, Shiode Y, Hirano M, Doi S, Toshima S, Takahashi K, Hosogi M, Ma X, Shiraga F.

Jpn J Ophthalmol. 2020 Mar;64(2):171-179. doi: 10.1007/s10384-020-00719-2. Epub 2020 Feb 3.

PMID:
32016665
10.

Correction: Motor planning error in Parkinson's disease and its clinical correlates.

Kawasaki T, Mikami K, Kamo T, Aoki R, Ishiguro R, Nakamura H, Tozawa R, Asada N, Hiiragi Y, Yamada Y, Hirano M, Katsuki K.

PLoS One. 2020 Jan 30;15(1):e0228698. doi: 10.1371/journal.pone.0228698. eCollection 2020.

11.

Background of the neuropathological site in neurocognitive decline in elderly schizophrenic patients.

Hirano M, Iritani S, Sekiguchi H, Torii Y, Habuchi C, Fujishiro H, Ozaki N, Yoshida M, Fujita K.

Psychogeriatrics. 2020 Jan 29. doi: 10.1111/psyg.12522. [Epub ahead of print]

PMID:
31994823
12.

West Nile virus capsid protein inhibits autophagy by AMP-activated protein kinase degradation in neurological disease development.

Kobayashi S, Yoshii K, Phongphaew W, Muto M, Hirano M, Orba Y, Sawa H, Kariwa H.

PLoS Pathog. 2020 Jan 23;16(1):e1008238. doi: 10.1371/journal.ppat.1008238. eCollection 2020 Jan.

13.

New paradigm for expediting drug development in Asia.

Rajman I, Hirano M, Honma W, Zhao S.

Drug Discov Today. 2020 Mar;25(3):491-496. doi: 10.1016/j.drudis.2019.12.013. Epub 2020 Jan 8.

14.

Plastid-targeted forms of restriction endonucleases enhance the plastid genome rearrangement rate and trigger the reorganization of its genomic architecture.

Sugimoto H, Hirano M, Tanaka H, Tanaka T, Kitagawa-Yogo R, Muramoto N, Mitsukawa N.

Plant J. 2020 Jan 11. doi: 10.1111/tpj.14687. [Epub ahead of print]

PMID:
31925982
15.

The C-terminal region affects the activity of photoactivated adenylyl cyclase from Oscillatoria acuminata.

Hirano M, Takebe M, Ishido T, Ide T, Matsunaga S.

Sci Rep. 2019 Dec 30;9(1):20262. doi: 10.1038/s41598-019-56721-3.

16.
17.

Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma.

Tanaka H, Kaneko N, Sakagami H, Matsuya T, Hiramoto M, Yamanaka Y, Mori M, Koshio H, Hirano M, Takeuchi M.

Leuk Res. 2020 Jan;88:106286. doi: 10.1016/j.leukres.2019.106286. Epub 2019 Dec 10.

PMID:
31865062
18.

Novel Mitochondrial Translation Optimizer-1 Mutations as a Cause of Hereditary Optic Neuropathy.

Li E, Emmanuele V, Testa F, Moreno CAM, Hirano M, Lesser RL.

J Neuroophthalmol. 2019 Dec 13. doi: 10.1097/WNO.0000000000000858. [Epub ahead of print] No abstract available.

PMID:
31842146
19.

Effects of Lyophilization of Arginine-rich Cell-penetrating Peptide-modified Extracellular Vesicles on Intracellular Delivery.

Noguchi K, Hirano M, Hashimoto T, Yuba E, Takatani-Nakase T, Nakase I.

Anticancer Res. 2019 Dec;39(12):6701-6709. doi: 10.21873/anticanres.13885.

PMID:
31810935
20.

Leber hereditary optic neuropathy plus dystonia, and transverse myelitis due to double mutations in MT-ND4 and MT-ND6.

Berardo A, Emmanuele V, Vargas W, Tanji K, Naini A, Hirano M.

J Neurol. 2020 Mar;267(3):823-829. doi: 10.1007/s00415-019-09619-z. Epub 2019 Nov 27.

PMID:
31776719
21.

A rare case of peliosis hepatis in a patient with chronic renal failure and renal cell carcinoma.

Maruyama H, Takahashi K, Ishikawa N, Hosaka K, Kumaki D, Aruga Y, Yamakawa M, Hirano M, Funakoshi K, Terai S.

Clin J Gastroenterol. 2019 Nov 11. doi: 10.1007/s12328-019-01068-5. [Epub ahead of print]

PMID:
31713159
22.

Potential mechanisms underlying embryonic developmental toxicity caused by benzo[a]pyrene in Japanese medaka (Oryzias latipes).

Yamaguchi A, Uchida M, Ishibashi H, Hirano M, Ichikawa N, Arizono K, Koyama J, Tominaga N.

Chemosphere. 2020 Mar;242:125243. doi: 10.1016/j.chemosphere.2019.125243. Epub 2019 Oct 31.

PMID:
31704526
23.

Enzyme-free release of adhered cells from standard culture dishes using intermittent ultrasonic traveling waves.

Kurashina Y, Imashiro C, Hirano M, Kuribara T, Totani K, Ohnuma K, Friend J, Takemura K.

Commun Biol. 2019 Oct 29;2:393. doi: 10.1038/s42003-019-0638-5. eCollection 2019.

24.

Development of Amphipathic Antimicrobial Peptide Foldamers Based on Magainin 2 Sequence.

Goto C, Hirano M, Hayashi K, Kikuchi Y, Hara-Kudo Y, Misawa T, Demizu Y.

ChemMedChem. 2019 Nov 20;14(22):1911-1916. doi: 10.1002/cmdc.201900460. Epub 2019 Nov 6.

PMID:
31667994
25.

Ancient BCMA-like Genes Herald B Cell Regulation in Lampreys.

Das S, Sutoh Y, Cancro MP, Rast JP, Han Q, Bommakanti G, Cooper MD, Hirano M.

J Immunol. 2019 Dec 1;203(11):2909-2916. doi: 10.4049/jimmunol.1900026. Epub 2019 Oct 30.

PMID:
31666307
26.

Reorganization of finger covariation patterns represented in the corticospinal system by learning of a novel movement irrelevant to common daily movements.

Hirano M, Funase K.

J Neurophysiol. 2019 Dec 1;122(6):2458-2467. doi: 10.1152/jn.00514.2019. Epub 2019 Oct 30.

PMID:
31664876
27.

Correction: A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: "eCura system".

Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Ohnita K, Yamanouchi K, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Hayashi Y, Nakamura T, Shimosegawa T.

Am J Gastroenterol. 2019 Dec;114(12):1925-1926. doi: 10.14309/ajg.0000000000000432. No abstract available.

PMID:
31658102
28.

Fatigue in primary genetic mitochondrial disease: No rest for the weary.

Parikh S, Galioto R, Lapin B, Haas R, Hirano M, Koenig MK, Saneto RP, Zolkipli-Cunningham Z, Goldstein A, Karaa A.

Neuromuscul Disord. 2019 Nov;29(11):895-902. doi: 10.1016/j.nmd.2019.09.012. Epub 2019 Sep 25.

PMID:
31653361
29.

Dystonia-Ataxia with early handwriting deterioration in COQ8A mutation carriers: A case series and literature review.

Galosi S, Barca E, Carrozzo R, Schirinzi T, Quinzii CM, Lieto M, Vasco G, Zanni G, Di Nottia M, Galatolo D, Filla A, Bertini E, Santorelli FM, Leuzzi V, Haas R, Hirano M, Friedman J.

Parkinsonism Relat Disord. 2019 Nov;68:8-16. doi: 10.1016/j.parkreldis.2019.09.015. Epub 2019 Sep 28. Review.

PMID:
31621627
30.

Developing a comprehensive career development scale for public health nurses in Japan.

Saeki K, Hirano M, Honda H, Asahara K.

Public Health Nurs. 2020 Jan;37(1):135-143. doi: 10.1111/phn.12673. Epub 2019 Oct 16.

PMID:
31617246
31.

Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.

Takenaka T, Nakai S, Katayama M, Hirano M, Ueno N, Noguchi K, Takatani-Nakase T, Fujii I, Kobayashi SS, Nakase I.

Int J Pharm. 2019 Dec 15;572:118762. doi: 10.1016/j.ijpharm.2019.118762. Epub 2019 Oct 11.

PMID:
31610280
32.

Nitric oxide plays a critical role in methotrexate-induced hyperplasia of enterochromaffin cells containing 5-hydroxytryptamine in rat small intestine.

Takano Y, Hirano M, Machida T, Obara Y, Hamaue N, Fujita K, Taniguchi M, Endo T, Shiga S, Machida M, Iizuka K, Hirafuji M.

J Pharmacol Sci. 2019 Sep;141(1):32-40. doi: 10.1016/j.jphs.2019.09.001. Epub 2019 Sep 10.

33.

Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure.

Rosenberg BJ, Hirano M, Quinzii CM, Colantuoni E, Needham DM, Lederer DJ, Baldwin MR.

Thorax. 2019 Nov;74(11):1099-1101. doi: 10.1136/thoraxjnl-2019-213621. Epub 2019 Sep 18.

34.

Redefining the Etiologic Landscape of Cerebellar Malformations.

Aldinger KA, Timms AE, Thomson Z, Mirzaa GM, Bennett JT, Rosenberg AB, Roco CM, Hirano M, Abidi F, Haldipur P, Cheng CV, Collins S, Park K, Zeiger J, Overmann LM, Alkuraya FS, Biesecker LG, Braddock SR, Cathey S, Cho MT, Chung BHY, Everman DB, Zarate YA, Jones JR, Schwartz CE, Goldstein A, Hopkin RJ, Krantz ID, Ladda RL, Leppig KA, McGillivray BC, Sell S, Wusik K, Gleeson JG, Nickerson DA, Bamshad MJ, Gerrelli D, Lisgo SN, Seelig G, Ishak GE, Barkovich AJ, Curry CJ, Glass IA, Millen KJ, Doherty D, Dobyns WB.

Am J Hum Genet. 2019 Sep 5;105(3):606-615. doi: 10.1016/j.ajhg.2019.07.019. Epub 2019 Aug 29.

35.

Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma.

Adilijiang A, Hirano M, Okuno Y, Aoki K, Ohka F, Maeda S, Tanahashi K, Motomura K, Shimizu H, Yamaguchi J, Wakabayashi T, Natsume A.

Molecules. 2019 Aug 22;24(17). pii: E3046. doi: 10.3390/molecules24173046.

36.

Catalytic cross-dimerisation giving reactive borylated polyenes toward cross-coupling.

Hirano M, Kuramochi A, Shimada K, Komine N, Kiyota S, Westcott SA.

Chem Commun (Camb). 2019 Aug 29;55(71):10527-10530. doi: 10.1039/c9cc05930j.

PMID:
31418006
37.

Advances in primary mitochondrial myopathies.

de Barcelos IP, Emmanuele V, Hirano M.

Curr Opin Neurol. 2019 Oct;32(5):715-721. doi: 10.1097/WCO.0000000000000743.

PMID:
31408013
38.

Activity of Adenylyl Cyclase Type 6 Is Suppressed by Direct Binding of the Cytoskeletal Protein 4.1G.

Saito M, Cui L, Hirano M, Li G, Yanagisawa T, Sato T, Sukegawa J.

Mol Pharmacol. 2019 Oct;96(4):441-451. doi: 10.1124/mol.119.116426. Epub 2019 Aug 5.

PMID:
31383768
39.

Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.

Lopez-Gomez C, Hewan H, Sierra C, Akman HO, Sanchez-Quintero MJ, Juanola-Falgarona M, Tadesse S, Tanji K, Konofagou EE, Hirano M.

EBioMedicine. 2019 Aug;46:356-367. doi: 10.1016/j.ebiom.2019.07.037. Epub 2019 Aug 2.

40.

Predominant surface property of an anodized titanium that enhances the cell response.

Ohtsu N, Kuji T, Hirano M, Yamasaki K.

Biointerphases. 2019 Jul 29;14(4):041002. doi: 10.1116/1.5108542.

PMID:
31357867
41.

Is Additional Surgery Always Sufficient for Preventing Recurrence After Endoscopic Submucosal Dissection with Curability C-2 for Early Gastric Cancer?

Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Oka S, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Ohnita K, Shimoda R, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Aoyagi H, Nakamura T, Nakaya N, Shimosegawa T, Masamune A.

Ann Surg Oncol. 2019 Oct;26(11):3636-3643. doi: 10.1245/s10434-019-07579-2. Epub 2019 Jul 24.

PMID:
31342376
42.

Specialized Somatosensory-Motor Integration Functions in Musicians.

Hirano M, Kimoto Y, Furuya S.

Cereb Cortex. 2019 Jul 25. pii: bhz154. doi: 10.1093/cercor/bhz154. [Epub ahead of print]

PMID:
31342056
43.

Spontaneous Tumor Regression of Intracranial Solitary Fibrous Tumor Originating From the Medulla Oblongata: A Case Report and Literature Review.

Yamaguchi J, Motomura K, Ohka F, Aoki K, Tanahashi K, Hirano M, Nishikawa T, Shimizu H, Wakabayashi T, Natsume A.

World Neurosurg. 2019 Oct;130:400-404. doi: 10.1016/j.wneu.2019.07.052. Epub 2019 Jul 18. Review.

PMID:
31326640
44.

Effects of the rotigotine transdermal patch versus oral levodopa on swallowing in patients with Parkinson's disease.

Hirano M, Isono C, Fukuda K, Ueno S, Nakamura Y, Kusunoki S.

J Neurol Sci. 2019 Sep 15;404:5-10. doi: 10.1016/j.jns.2019.07.003. Epub 2019 Jul 9.

PMID:
31323520
45.

Rational design of novel amphipathic antimicrobial peptides focused on the distribution of cationic amino acid residues.

Misawa T, Goto C, Shibata N, Hirano M, Kikuchi Y, Naito M, Demizu Y.

Medchemcomm. 2019 Apr 4;10(6):896-900. doi: 10.1039/c9md00166b. eCollection 2019 Jun 1.

PMID:
31303986
46.

Pathological Findings in Male Patients With Anti-N-methyl-d-Aspartate Receptor Encephalitis.

Hirano M, Itoh T, Fujimura H, Inoue K, Samukawa M, Nose K, Sakamoto H, Maekura S, Ueno S, Satou T, Nishioka T, Kusunoki S, Nakamura Y.

J Neuropathol Exp Neurol. 2019 May 31. pii: nlz052. doi: 10.1093/jnen/nlz052. [Epub ahead of print]

PMID:
31282957
47.

Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.

Hirano M, Iritani S, Fujishiro H, Torii Y, Habuchi C, Sekiguchi H, Yoshida M, Ozaki N.

Neuropathology. 2019 Oct;39(5):331-341. doi: 10.1111/neup.12578. Epub 2019 Jul 2.

PMID:
31264738
48.

Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.

Inami H, Shishikura JI, Yasunaga T, Hirano M, Kimura T, Yamashita H, Ohno K, Sakamoto S.

Chem Pharm Bull (Tokyo). 2019;67(7):699-706. doi: 10.1248/cpb.c18-00977.

49.

In vitro assessment of effects of persistent organic pollutants on the transactivation of estrogen receptor α and β (ERα and ERβ) from the Baikal seal (Pusa sibirica).

Yoshinouchi Y, Shimizu S, Lee JS, Hirano M, Suzuki KT, Kim EY, Iwata H.

Ecotoxicol Environ Saf. 2019 Oct 15;181:463-471. doi: 10.1016/j.ecoenv.2019.06.033. Epub 2019 Jun 19.

PMID:
31228822
50.

Different characteristics of postoperative atrial tachyarrhythmias between congenital and non-congenital heart disease.

Kondo M, Fukuda K, Wakayama Y, Nakano M, Hasebe Y, Satake H, Segawa M, Hirano M, Shimokawa H.

J Interv Card Electrophysiol. 2019 Jun 13. doi: 10.1007/s10840-019-00575-2. [Epub ahead of print]

PMID:
31197584

Supplemental Content

Loading ...
Support Center